Related Experiment Video
Updated: Jun 20, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
A comparison of phase II study strategies
Sally Hunsberger1, Yingdong Zhao, Richard Simon
1Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland 20892, USA. sallyh@ctep.nci.nih.gov
Summary
Traditional oncology drug development faces challenges with single-arm phase II studies. Randomized phase II studies offer more insight but require more time and patients for evaluating new cancer drugs.
Area of Science:
- Oncology
- Clinical Trial Design
- Drug Development
Background:
- The conventional oncology drug development pathway, involving single-arm phase II studies followed by randomized phase III studies, presents significant limitations in the current era.
- Interpreting single-arm phase II study outcomes becomes challenging when novel drugs are administered in combination regimens or when progression-free survival is the primary endpoint, rather than tumor shrinkage.
Purpose of the Study:
- To compare various phase II clinical trial designs.
- To identify the most efficient drug development strategy regarding patient numbers and study duration for assessing overall survival efficacy of new oncology agents.
Main Methods:
- Comparative analysis of different phase II study designs.
- Evaluation of efficiency based on patient accrual and time to definitive efficacy conclusions.
Main Results:
- Single-arm phase II studies present interpretation difficulties with combination therapies and novel endpoints like progression-free survival.
- Randomized phase II studies provide more robust data but necessitate larger patient cohorts and extended timelines.
Conclusions:
- Optimizing phase II study design is crucial for efficient oncology drug development.
- Balancing the need for informative data with resource constraints is key to advancing new cancer therapies.
Related Concept Videos
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:20Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
01:20Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...